【摘要】：目的探討PARP1在β-拉帕醌殺傷人AGS胃癌細(xì)胞珠中的作用及分子機(jī)制。方法1.選擇人AGS胃癌細(xì)胞株,設(shè)計(jì)并合成3個(gè)針對(duì)靶基因PARP1的siRNA寡核苷酸基因片段,以及陰性對(duì)照組NC-siRNA,采用常規(guī)瞬時(shí)轉(zhuǎn)染的方法干擾PARP-1 表達(dá)。2.轉(zhuǎn)染后分別對(duì)4組加入4μmol/L的β-拉帕醌,采用Western blot實(shí)驗(yàn)檢測(cè)四組PARP1裂解產(chǎn)物蛋白的表達(dá)變化,采用方差分析進(jìn)行比較,篩選出穩(wěn)定的轉(zhuǎn)染細(xì)胞株;3.選取已篩選出的siRNA重新轉(zhuǎn)染AGS細(xì)胞珠,同時(shí)設(shè)置陰性對(duì)照組NC-siRNA組;采用MTT實(shí)驗(yàn)及平板克隆實(shí)驗(yàn)分別檢測(cè)目的基因轉(zhuǎn)染組(PARP1-siRNA轉(zhuǎn)染組)、NC-siRNA對(duì)照組中β-拉帕醌對(duì)AGS細(xì)胞珠增殖及克隆能力的影響;用劃痕實(shí)驗(yàn)檢測(cè)PARP1-siRNA轉(zhuǎn)染組、NC-siRNA對(duì)照組中β-拉帕醌對(duì)AGS細(xì)胞珠遷移能力的影響。結(jié)果1.AGS胃癌細(xì)胞珠轉(zhuǎn)染后的轉(zhuǎn)染效率:在顯微鏡下觀察轉(zhuǎn)染后48h的細(xì)胞形態(tài),與陰性對(duì)照組相比,PARP1基因經(jīng)siRNA抑制表達(dá)后在形態(tài)上未見(jiàn)明顯改變,貼壁生長(zhǎng),呈圓形,可見(jiàn)PARP1基因沉默對(duì)細(xì)胞的形態(tài)生長(zhǎng)無(wú)顯著的影響。Western blot檢測(cè)轉(zhuǎn)染(已加入4μmol/Lβ-拉帕醌)'后72h目的基因PARP1裂解產(chǎn)物蛋白的表達(dá):與NC-siRNA對(duì)照組相比,siRNA組PARP1的裂解產(chǎn)蛋白的表達(dá)顯著降低,PARP1-siRNA 1 下降了 89%(P0.01),PARP1-siRNA 2 下降了 73%(P0.05),PARP1-siRNA3下降了 83%(P0.05),與另外三組相比,轉(zhuǎn)染后蛋白表達(dá)水平較低的是PARP1-siRNA 1組,說(shuō)明PARP1-siRNA 1是最有效和最特異的序列,可以用于干擾沉默PARP1基因的表達(dá),并用于后續(xù)實(shí)驗(yàn)。2.PARP1-siRNA轉(zhuǎn)染對(duì)AGS細(xì)胞珠增殖、克隆及遷移能力的影響:MTT、平板克隆實(shí)驗(yàn)、劃痕實(shí)驗(yàn)可以觀察到β-拉帕醌可顯著抑制NC-siRNA對(duì)照組組細(xì)胞的增殖、克隆及遷移能力,而對(duì)PARP1-siRNA轉(zhuǎn)染組的抑制效果明顯減弱;siRNA沉默PARP1基因表達(dá)后可顯著降低β-拉帕醌對(duì)胃癌細(xì)胞的殺傷力。結(jié)論1.使用RNA干擾技術(shù)可以成功抑制AGS胃癌細(xì)胞珠中PARP 1基因的表達(dá)。2.過(guò)度活化的PARP1在β-拉帕醌殺傷胃癌細(xì)胞中發(fā)揮著關(guān)鍵作用。
[Abstract]:Objective to investigate the role of PARP1 in killing human AGS gastric cancer cells and its molecular mechanism. Method 1. Three siRNA oligonucleotide fragments targeting the target gene PARP1 and NC-siRNAs of negative control group were designed and synthesized from human AGS gastric cancer cell lines. The expression of PARP-1 was interfered with by conventional transient transfection. After transfection, 4 渭 mol / L 尾 -lappa quinone was added to the four groups. The protein expression of the four groups of PARP1 cleavage products was detected by Western blot assay, and the stable transfected cell line was screened by variance analysis. The selected siRNA was retransfected into AGS cells, and the negative control group was set up in NC-siRNA group. MTT assay and plate cloning assay were used to detect the effects of 尾 -lapraquinone on the proliferation and cloning ability of AGS cells in the target gene transfected group (PARP1-siRNA transfected group). The effect of 尾 -lapraquinone on the migration of AGS cells was detected by scratch test in the control group of PARP1-siRNA transfection group. Results 1. Transfection efficiency after transfection of AGS gastric cancer cell beads: the morphology of the cells was observed under microscope at 48h after transfection. Compared with the negative control group, the expression of PARP1 gene did not change significantly after siRNA inhibition, and the cells grew round and adherent to the wall. 2. It can be seen that paRP1 gene silencing has no significant effect on cell morphological growth. Western blot was used to detect the protein expression of the target gene PARP1 cleavage product 72 h after transfection (4 渭 mol / L 尾 -lapraquinone): compared with NC-siRNA control group, the cleavage of PARP1 produced protein in siRNA group. The expression of PARP1-siRNA1 decreased by 89% (P0.01) and PARP1-siRNA2 decreased by 73% (P0.05), and the expression of PARP1-siRNA3 decreased by 83% (P0.05), compared with the other three groups. The protein expression level of PARP1-siRNA1 group was lower after transfection, indicating that PARP1-siRNA1 was the most effective and specific sequence, which could be used to interfere with the silencing of PARP1 gene expression, and to further experiment .2.PARP1-siRNA transfection on the proliferation of AGS cells. The effects of cloning and migration ability on cell proliferation, cloning and migration of NC-siRNA control group were observed by using 尾 -lapraquinone as control group, and the proliferation, cloning and migration of NC-siRNA control group were significantly inhibited by 尾 -lapraquinone. The inhibitory effect of PARP1-siRNA transfection group on PARP1 gene expression was significantly decreased after silencing PARP1 gene expression by siRNA. The inhibitory effect of 尾 -lapraquinone on gastric cancer cells was significantly decreased. Conclusion 1. The expression of PARP1 gene in AGS gastric cancer cells was successfully inhibited by RNA interference. Overexpression of PARP1 plays a key role in killing gastric cancer cells by 尾-lapanone.
【學(xué)位授予單位】：延邊大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類(lèi)號(hào)】：R735.2

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 高羽亭;杜進(jìn)林;楊慧;唐煥文;;沉默PARP-1對(duì)氫醌所致大鼠骨髓間充質(zhì)干細(xì)胞凋亡影響[J];中國(guó)職業(yè)醫(yī)學(xué);2017年01期

2 劉悅;焦冰洋;于楠楠;王闖;韓英浩;金成浩;孫虎男;;β-拉帕醌通過(guò)下調(diào)過(guò)氧化物酶V誘導(dǎo)SW480結(jié)腸癌細(xì)胞凋亡[J];中國(guó)細(xì)胞生物學(xué)學(xué)報(bào);2016年12期

3 徐敏;邱雷;郭連峰;趙寧;張憲軍;張麗娟;;AIF對(duì)人宮頸癌Hela細(xì)胞體外生物學(xué)活性的影響及機(jī)制研究[J];重慶醫(yī)學(xué);2016年32期

4 侯立春;林黎娟;;NQO1高表達(dá)提示宮頸癌預(yù)后不良[J];實(shí)用腫瘤學(xué)雜志;2016年04期

5 潘理會(huì);張平;李春輝;;PI3K/AKT/mTOR信號(hào)傳導(dǎo)通路在胃癌中的研究進(jìn)展[J];承德醫(yī)學(xué)院學(xué)報(bào);2016年04期

6 陳利俊;馬麗;李莉萍;;聚腺苷二磷酸-核糖聚合酶1與DNA雙鏈斷裂修復(fù)的相關(guān)性[J];中國(guó)生物化學(xué)與分子生物學(xué)報(bào);2016年06期

7 宋仕茂;陳宇;張治國(guó);駱志國(guó);;胃癌細(xì)胞SGC7901凋亡的PI3K/Akt通路介導(dǎo)作用及雷帕霉素的作用機(jī)制分析[J];癌癥進(jìn)展;2016年06期

8 胡中慧;馬慧萍;李加恒;賈正平;;線粒體自噬在缺氧條件下適應(yīng)機(jī)制的研究進(jìn)展[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2016年08期

9 陳磊;;胃癌患者術(shù)前預(yù)后營(yíng)養(yǎng)指數(shù)與輔助化療效果及預(yù)后的關(guān)系[J];中國(guó)醫(yī)學(xué)前沿雜志(電子版);2016年02期

10 王月霞;陳敏;;自噬性細(xì)胞死亡及其與細(xì)胞凋亡、壞死關(guān)系研究進(jìn)展[J];中國(guó)公共衛(wèi)生;2016年10期

相關(guān)會(huì)議論文 前3條

1 代淑陽(yáng);郭志敏;蔡夢(mèng);李薇;趙曉航;;RIP3激酶活性非依賴的細(xì)胞DNA損傷修復(fù)功能[A];全國(guó)腫瘤流行病學(xué)和腫瘤病因?qū)W學(xué)術(shù)會(huì)議論文集[C];2015年

2 劉慧穎;程學(xué)芳;李清然;王洪;王廣基;郝海平;;NQO1靶向藥物調(diào)控NAD+合成代謝及誘導(dǎo)細(xì)胞凋亡作用機(jī)理研究[A];2014年創(chuàng)新藥物成藥性評(píng)價(jià)高層學(xué)術(shù)論壇報(bào)告匯編[C];2014年

3 蒲詠梅;張東才;;細(xì)胞凋亡過(guò)程中的鈣信號(hào)研究[A];首屆粵港生物物理學(xué)術(shù)研討會(huì)論文集[C];1999年

相關(guān)博士學(xué)位論文 前4條

1 王凌波;聚二磷酸腺苷核糖聚合酶1在急性髓系白血病中的作用及機(jī)制研究[D];山東大學(xué);2016年

2 鄭林杰;JNK在氧化應(yīng)激導(dǎo)致膠質(zhì)瘤細(xì)胞Parthanatos中的作用及機(jī)制研究[D];吉林大學(xué);2016年

3 周憲春;β-拉帕醌通過(guò)EMT抑制乳腺癌侵襲轉(zhuǎn)移的機(jī)制研究[D];延邊大學(xué);2016年

4 秦云植;NQO1及其抑制劑在胃癌預(yù)后評(píng)估及靶向治療中的作用研究[D];延邊大學(xué);2015年

相關(guān)碩士學(xué)位論文 前4條

1 樊彩芳;PARP-1/AIF通路介導(dǎo)戊二酸尿癥Ⅰ型大鼠大腦皮質(zhì)損傷的機(jī)制研究[D];鄭州大學(xué);2015年

2 楊洋;醌氧化還原酶及其抑制劑在乳腺癌增殖與遷移中的作用研究[D];延邊大學(xué);2015年

3 姚圓圓;PARP-1抑制劑PJ34對(duì)人肺腺癌順鉑耐藥細(xì)胞A549/DDP生長(zhǎng)活性及耐藥性的影響[D];安徽醫(yī)科大學(xué);2015年

4 金丹;宮頸鱗狀細(xì)胞癌中NQO1蛋白過(guò)表達(dá)的臨床病理學(xué)意義[D];延邊大學(xué);2014年

，

本文編號(hào)：2126900